Zhou, W.; Huang, J.; Xiao, Q.; Hu, S.; Li, S.; Zheng, J.; Du, Z.; Peng, J.; Chen, H.
Glu-Urea-Lys Scaffold Functionalized Superparamagnetic Iron Oxide Nanoparticles Targeting PSMA for In Vivo Molecular MRI of Prostate Cancer. Pharmaceutics 2022, 14, 2051.
https://doi.org/10.3390/pharmaceutics14102051
AMA Style
Zhou W, Huang J, Xiao Q, Hu S, Li S, Zheng J, Du Z, Peng J, Chen H.
Glu-Urea-Lys Scaffold Functionalized Superparamagnetic Iron Oxide Nanoparticles Targeting PSMA for In Vivo Molecular MRI of Prostate Cancer. Pharmaceutics. 2022; 14(10):2051.
https://doi.org/10.3390/pharmaceutics14102051
Chicago/Turabian Style
Zhou, Wei, Jiandong Huang, Qingwei Xiao, Shunmin Hu, Shijia Li, Jie Zheng, Zhiyun Du, Jiangling Peng, and Huixiong Chen.
2022. "Glu-Urea-Lys Scaffold Functionalized Superparamagnetic Iron Oxide Nanoparticles Targeting PSMA for In Vivo Molecular MRI of Prostate Cancer" Pharmaceutics 14, no. 10: 2051.
https://doi.org/10.3390/pharmaceutics14102051
APA Style
Zhou, W., Huang, J., Xiao, Q., Hu, S., Li, S., Zheng, J., Du, Z., Peng, J., & Chen, H.
(2022). Glu-Urea-Lys Scaffold Functionalized Superparamagnetic Iron Oxide Nanoparticles Targeting PSMA for In Vivo Molecular MRI of Prostate Cancer. Pharmaceutics, 14(10), 2051.
https://doi.org/10.3390/pharmaceutics14102051